{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:48:39Z","timestamp":1769226519476,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T00:00:00Z","timestamp":1403913600000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.neo.2014.05.012","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T18:19:39Z","timestamp":1406398779000},"page":"471-480","source":"Crossref","is-referenced-by-count":28,"title":["Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration"],"prefix":"10.1016","volume":"16","author":[{"given":"Ana P.","family":"Berbegall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Villam\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Tadeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy","family":"Martinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adela","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Noguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2014.05.012_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/pbc.24777","article-title":"Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project","volume":"61","author":"Mosse","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pbc.20859","article-title":"Neuroblastoma in adults: Incidence and survival analysis based on SEER data","volume":"49","author":"Esiashvili","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0015","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/cncr.21751","article-title":"Neuroblastoma in adolescents: the Italian experience","volume":"106","author":"Conte","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0020","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/030089161009600507","article-title":"Neuroblastoma in patients over 12 years old: a 20-year experience at the Istituto Nazionale Tumori of Milan","volume":"96","author":"Podda","year":"2010","journal-title":"Tumori"},{"key":"10.1016\/j.neo.2014.05.012_bb0025","first-page":"952645","article-title":"Neuroblastoma in the Elderly and SIADH: Case Report and Review of the Literature","author":"Pellegrino","year":"2012","journal-title":"Case Rep Med"},{"key":"10.1016\/j.neo.2014.05.012_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12094-010-0466-z","article-title":"Neuroblastoma in adolescents: genetic and clinical characterisation","volume":"12","author":"Castel","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0035","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<2028::AID-CNCR26>3.0.CO;2-V","article-title":"Neuroblastoma in adults and adolescents: an indolent course with poor survival","volume":"79","author":"Franks","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mpo.10273","article-title":"Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience","volume":"41","author":"Kushner","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0045","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.25987","article-title":"Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults","volume":"117","author":"Polishchuk","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0050","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/cncr.25232","article-title":"Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma","volume":"116","author":"Kushner","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0055","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/bjc.2011.472","article-title":"Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable\/disseminated neuroblastoma (a SIOPEN collaborative study)","volume":"105","author":"Schleiermacher","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0060","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1073\/pnas.0910684107","article-title":"High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset","volume":"107","author":"Car\u00e9n","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2014.05.012_bb0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.onc.1210661","article-title":"Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature","volume":"27","author":"Tomioka","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2014.05.012_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2012.228","article-title":"Association of age at diagnosis and genetic mutations in patients with neuroblastoma","volume":"307","author":"Cheung","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.neo.2014.05.012_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature10910","article-title":"Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes","volume":"483","author":"Molenaar","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neo.2014.05.012_bb0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2529","article-title":"The genetic landscape of high-risk neuroblastoma","volume":"45","author":"Pugh","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.neo.2014.05.012_bb0085","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2011.40.9169","article-title":"Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma","volume":"30","author":"Asgharzadeh","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-5876-9-170","article-title":"Distinct signatures of the immune responses in low risk versus high risk neuroblastoma","volume":"9","author":"Gowda","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.neo.2014.05.012_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2008.00600.x","article-title":"Polarized immune responses differentially regulate cancer development","volume":"222","author":"Johansson","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.neo.2014.05.012_bb0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/157339609788185686","article-title":"Research advances in neuroblastoma immunotherapy","volume":"5","author":"Booker","year":"2009","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.neo.2014.05.012_bb0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4161\/mabs.25215","article-title":"Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study","volume":"5","author":"Ladenstein","year":"2013","journal-title":"mAbs"},{"key":"10.1016\/j.neo.2014.05.012_bb0110","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neo.2014.05.012_bb0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1043-4666(92)90078-6","article-title":"Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans","volume":"4","author":"Granowitz","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.neo.2014.05.012_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.semcancer.2011.09.012","article-title":"Immunology and immunotherapy of neuroblastoma","volume":"21","author":"Seeger","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.neo.2014.05.012_bb0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The International Neuroblastoma Pathology Classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0130","doi-asserted-by":"crossref","first-page":"e53740","DOI":"10.1371\/journal.pone.0053740","article-title":"Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion","volume":"8","author":"Villamon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2014.05.012_bb0135","first-page":"215","article-title":"Multiplex Ligation-Dependent Probe Amplification (MLPA) on FPPE Tissue","author":"Berbegall","year":"2010"},{"key":"10.1016\/j.neo.2014.05.012_bb0140","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/0008-5472.CAN-05-0465","article-title":"A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays","volume":"65","author":"Nannya","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0145","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","article-title":"International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee","volume":"100","author":"Ambros","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0150","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/1078-0432.CCR-10-0830","article-title":"A multilocus technique for risk evaluation of patients with neuroblastoma","volume":"17","author":"Ambros","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0155","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/gcc.20496","article-title":"ArrayCGH-based classification of neuroblastoma into genomic subgroups","volume":"46","author":"Michels","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0160","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1200\/JCO.2008.16.0630","article-title":"Overall genomic pattern is a predictor of outcome in neuroblastoma","volume":"27","author":"Janoueix-Lerosey","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/1471-2164-12-443","article-title":"Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors","volume":"12","author":"Kryh","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.neo.2014.05.012_bb0170","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.2005.06.104","article-title":"Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma","volume":"23","author":"Vandesompele","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0175","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-05-2495","article-title":"Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma","volume":"12","author":"Spitz","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cancergencyto.2005.09.001","article-title":"Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma","volume":"167","author":"Spitz","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.neo.2014.05.012_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2407-13-231","article-title":"Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation","volume":"13","author":"Cetinkaya","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0190","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/1078-0432.CCR-08-1648","article-title":"Heterogeneity of the MYCN oncogene in neuroblastoma","volume":"15","author":"Theissen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1096-911X(20010101)36:1<1::AID-MPO1002>3.0.CO;2-L","article-title":"Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas","volume":"36","author":"Ambros","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/cncr.11521","article-title":"Neuroblastoma in adolescents","volume":"98","author":"Gaspar","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0205","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/1097-0142(19950901)76:5<890::AID-CNCR2820760525>3.0.CO;2-X","article-title":"Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis","volume":"76","author":"Blatt","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0210","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1200\/JCO.2009.26.7955","article-title":"Accumulation of segmental alterations determines progression in neuroblastoma","volume":"28","author":"Schleiermacher","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0215","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1593\/neo.121114","article-title":"High genomic instability predicts survival in metastatic high-risk neuroblastoma","volume":"14","author":"Stigliani","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2014.05.012_bb0220","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2012.375","article-title":"Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project","volume":"107","author":"Schleiermacher","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2559.2011.03899.x","article-title":"Prognostic value of partial genetic instability in neuroblastoma with \u226450% neuroblastic cell content","volume":"59","author":"Piqueras","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.neo.2014.05.012_bb0230","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.27432","article-title":"Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma","volume":"131","author":"Coco","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2014.05.012_bb0235","doi-asserted-by":"crossref","first-page":"e72182","DOI":"10.1371\/journal.pone.0072182","article-title":"Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis","volume":"8","author":"Boeva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2014.05.012_bb0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/CCO.0000000000000038","article-title":"Prevalence and clinical implications of chromothripsis in cancer genomes","volume":"26","author":"Kloosterman","year":"2014","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0245","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1101\/gr.143677.112","article-title":"Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms","volume":"23","author":"Malhotra","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0250","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cell.2013.04.010","article-title":"Diverse mechanisms of somatic structural variations in human cancer genomes","volume":"153","author":"Yang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neo.2014.05.012_bb0255","doi-asserted-by":"crossref","first-page":"e77731","DOI":"10.1371\/journal.pone.0077731","article-title":"Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2014.05.012_bb0260","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neo.2014.05.012_bb0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neo.2014.05.012_bb0270","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/pr.2013.217","article-title":"Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma","volume":"75","author":"Tadeo","year":"2014","journal-title":"Pediatr Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0275","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neo.2014.05.012_bb0280","doi-asserted-by":"crossref","first-page":"e23618","DOI":"10.4161\/onci.23618","article-title":"The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes","volume":"2","author":"Carlson","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.neo.2014.05.012_bb0285","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mpo.1139","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features\u2014a report from the Children's Cancer Group","volume":"36","author":"Cooper","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0290","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00262-011-1071-x","article-title":"Prognostic impact of B-cell density in cutaneous melanoma","volume":"60","author":"Ladanyi","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.neo.2014.05.012_bb0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-\u03b1 in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl 1","key":"10.1016\/j.neo.2014.05.012_bb0300","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1038\/sj.bjp.0706400","article-title":"The role of inflammation in CNS injury and disease","volume":"147","author":"Lucas","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neo.2014.05.012_bb0305","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neo.2014.05.012_bb0310","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neo.2014.05.012_bb0315","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00262-012-1253-1","article-title":"Tumor microenvironment and lymphocyte infiltration","volume":"61","author":"Rahir","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.neo.2014.05.012_bb0320","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-11-1316","article-title":"Prognostic and predictive impact of intra- and peritumoral immune infiltrates","volume":"71","author":"Fridman","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0325","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1158\/1078-0432.CCR-05-1824","article-title":"Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors","volume":"12","author":"Vakkila","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0330","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.20092454","article-title":"Tumor masses support naive T cell infiltration, activation, and differentiation into effectors","volume":"207","author":"Thompson","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.neo.2014.05.012_bb0335","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/carcin\/bgt009","article-title":"Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma","volume":"34","author":"Carlson","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neo.2014.05.012_bb0340","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/1078-0432.CCR-12-2528","article-title":"Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells","volume":"19","author":"Santilli","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2014.05.012_bb0345","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/intimm\/13.4.593","article-title":"CD11b expression as a marker to distinguish between recently activated effector CD8+ T cells and memory cells","volume":"13","author":"Christensen","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.neo.2014.05.012_bb0350","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1200\/JCO.2005.05.3314","article-title":"Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma","volume":"24","author":"Coughlin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2014.05.012_bb0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biosystems.2010.07.008","article-title":"An in silico platform for the study of epithelial pre-invasive neoplastic development","volume":"102","author":"Guillaud","year":"2010","journal-title":"Biosystems"},{"key":"10.1016\/j.neo.2014.05.012_bb0360","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semcancer.2013.05.009","article-title":"Cooperation and competition in the dynamics of tissue architecture during homeostasis and tumorigenesis","volume":"23","author":"Csikasz-Nagy","year":"2013","journal-title":"Semin Cancer Biol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558614000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558614000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T19:42:35Z","timestamp":1649792555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558614000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1476558614000670"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2014.05.012","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}